Amplification efficiency and cost analysis of MP-NAT and ID-NAT in blood samples
Journal Title: Chinese Journal of Blood Transfusion - Year 2023, Vol 36, Issue 4
Abstract
Objective To compare the performance and cost-effectiveness between ID-NAT (individual detection of NAT) mode and MP-NAT (mini-pool nucleic acid test) mode in blood screening, and to provide reference for blood sample detection. Methods The results of 95 895 NAT-samples completed in 2021 were analyzed, and the Ct values of MP-NAT positive/ID-NAT negative group, MP-NAT positive/ID-NAT positive group, MP-NAT negative/ID-NAT positive group were compared. The amplification efficiency of MP-NAT and ID-NAT mode was estimated by PCR. Twelve samples from MP-NAT negative/ ID-NAT positive group were simulated by MP-NAT for 5 to 10 times. Results The Ct values of samples by MP-NAT were significantly higher than those by ID-NAT(P<0.05). The amplification efficiency of MP6-NAT was 0.16-0.71 times higher than that of ID-NAT. Among the 12 samples with MP-NAT-/ ID-NAT+, 11 samples were tested positive at least once after simulated 5 to 10 times by MP-NAT, and ELISA-HBsAg was 0.3<S/Co<Cutoff in 11 samples. Compared with MP-NAT, ID-NAT prolonged the run time of equipment by 3.5 times and increase the cost by 5.9 times. Conclusion The amplification efficiency of MP-NAT is lower than that of ID-NAT, and samples with lower viral load are prone to be missed in MP-NAT. However, the running-time and cost of ID-NAT are 3.5-5.9 times of those of MP-NAT.It is recommended to promote ID-NAT in areas with high HBV prevalence.
Authors and Affiliations
Ziyi HE, Guowei HAN, Qingkai CHEN, Qing WANG, Shaobin CHEN, Lin YU
Keywords
Related Articles
- EP ID EP738533
- DOI 10.13303/j.cjbt.issn.1004-549x.2023.04.013
- Views 27
- Downloads 0
Changes and distribution of antibodies in plasma before and after infection of SARS-CoV-2 Omicron strain
Objective To determine the best collection time period of plasma which can be used for human COVID-19 immunoglobulin for intravenous injection through SARS-CoV-2-IgG change and neutralizing antibody distribution against...
Comparison of clinical efficacy of fibrinogen concentrate and cryoprecipitate on severe postpartum hemorrhage in puerpera with placenta accreta
Objective To explore the therapeutic effect of fibrinogen concentrate and cryoprecipitate on severe postpartum hemorrhage in puerpera with placenta accreta under the condition of transfusion of suspended red blood cells...
Cost-benefit analysis of hepatitis B virus serological and nucleic acid testing in blood donors
Objective In an effort to prevent transfusion-transmitted hepatitis B infection, universal HBsAg screening, HBsAg+ MP nucleic acid test(NAT) for HBV and HBsAg + individual(ID) NAT were analyzed for cost-effectiveness. Me...
Risk factors analysis of blood type unexpected antibody in large sample of inpatients
Objective To observe and analyze the detection results of blood type unexpected antibody and its risk factors in inpatients, so as to provide reference for promoting the safety of clinical blood transfusion. Methods Clin...
Blood transfusion compatibility in patients with delayed serologic transfusion reaction: a retrospective analysis of 6 cases
Objective To retrospectively analyze the characteristics of blood transfusion compatibility detection in patients with delayed serologic transfusion reaction ( DSTR), in order to provide reference for safe and effective...